Market revenue in 2024 | USD 1,202.5 million |
Market revenue in 2030 | USD 1,686.9 million |
Growth rate | 5.8% (CAGR from 2024 to 2030) |
Largest segment | Defibrillators |
Fastest growing segment | Defibrillators |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Pacemakers, Defibrillators, Cardiac Resynchronization Therapy (CRT) |
Key market players worldwide | Stryker Corp, BIOTRONIK, SCHILLER, Medtronic PLC, Abbott Laboratories, Koninklijke Philips NV, ZOLL Medical Corporation, Boston Scientific Corp, LivaNova PLC, Progetti Medical |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cardiac rhythm management devices market will help companies and investors design strategic landscapes.
Defibrillators was the largest segment with a revenue share of 36.46% in 2024. Horizon Databook has segmented the Germany cardiac rhythm management devices market based on pacemakers, defibrillators, cardiac resynchronization therapy (crt) covering the revenue growth of each sub-segment from 2018 to 2030.
Congenital Heart Defects (CHD) and diseases have been a major driver of the EP devices market in Germany. These conditions can lead to arrhythmias and other cardiac problems, which require the use of EP devices for diagnosis & treatment. According to figures from the latest Deutscher Herzbericht 2022, a total of 121,172 people died in 2021 of CHD, and 45,181 of them had an acute heart attack.
The death rate for CHD was thus 129.7 deaths per 100,000 citizens. As a result, there has been an increasing demand for CRM devices in Germany, particularly those used for catheter ablation and other minimally invasive procedures. The CRM devices market in Germany has been driven by advancements in technology, which have led to the development of more effective & safe devices.
Technological advancements have enabled the development of more advanced devices that offer better monitoring, diagnostic capabilities, and treatment options for patients with cardiac conditions. These devices are also more user-friendly and easier to implant, which has resulted in improved patient outcomes.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany cardiac rhythm management devices market, including forecasts for subscribers. This country databook contains high-level insights into Germany cardiac rhythm management devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account